# Canopy Growth Corporation (WEED.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Healthcare / Pharmaceuticals. Price C$1.35, market value C$642 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Canopy Growth Corporation reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.0×**. Each dollar of revenue is priced at 2.0×.
- **Price / book: 0.7×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: -14.2%** (5-yr avg -36.4%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 22.9%**. Canopy Growth Corporation keeps 22.9% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: -46.9%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -92.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -37.7%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -24.7%**. Return on all capital, debt included, is -24.7%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -21.1%**. Each dollar of assets produces -21.1% of profit.

## Growth
- **Revenue growth (1 yr): 5.8%** (3-yr -5.1%/yr, 5-yr -12.2%/yr). Revenue grew 5.8% over the last year, against -12.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 86.3%**. Earnings per share rose 86.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.40**. Debt is 0.40 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 2.7×**. It would take 2.7 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: -3.4×**. Operating profit covers interest only -3.4×: fragile.
- **Current ratio: 3.34** (quick 2.64). Current assets cover the next year's liabilities 3.34 times.
- **Altman Z-score: 2.22**. A Z-score of 2.22 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Canopy Growth Corporation does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -29.3%** (YTD -13.5%, 3-mo -6.3%). The shares are down 29.3% over twelve months including dividends.
- **From 52-week high: -58.8%** (14.4% above the low). Trading 59% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 45**. An RSI of 45 is neutral.
- **Beta (1 yr): 1.27** (volatility 86%). Beta of 1.27 against the S&P/TSX Composite: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=WEED.TO · Page: https://foliofundamentals.com/stocks/weed.to

Not investment advice.